ST. LOUIS – Prostate cancer is the second most common cancer in men. Siteman Cancer Center’s top Urological Surgeon joined FOX 2 to discuss the effectiveness of a new urine test for prostate cancer.
Dr. Andriole is part of an international team of researchers that is evaluating the effectiveness of a new urine test for prostate cancer. The test, called Exodx Prostate.
The test could reduce the need for biopsies of slow-growing, non-aggressive forms of prostate cancer, which often call for close monitoring rather than near-term surgery.
For more information: siteman.Wustl.Edu